Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

Shanghai Yao Yuan Biotechnology Ltd., also known as Drug Farm, is advancing a portfolio of immune-modulating therapies for various indications including hepatitis B virus, hepatocellular cancer and a ...

Hematological diseases can cause massive splenomegaly and portal hypertension via portal vein thrombosis, liver infiltration by malignant cells, or in association with NRH. Myelofibrosis.

Panelists discuss how the MOMENTUM trial demonstrated momelotinib’s superiority over danazol in symptomatic anemic myelofibrosis patients, showing significant improvements in symptoms (the primary end ...

Cytopenia and splenomegaly appear to be the main drivers for poor prognosis in patients with myelofibrosis (MF) who discontinue ruxolitinib, according to a recently published study in the journal SSRN ...

ROSAH (retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis and headache) syndrome is a rare, autosomal dominant autoinflammatory genetic disease named according to the characteristic ...

on fedratinib (Inrebic) for treating disease-related splenomegaly or symptoms of primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis in adults ...

Splenomegaly, or an enlarged spleen, often occurs in connection with immune-related conditions and is seen in a variety of diseases, including autoimmune disorders and chronic infections.

In Cureus, physicians presented the case of a patient with splenomegaly and sustained thrombocytopenia who was eventually diagnosed with systemic mastocytosis (SM). A 63-year-old man was referred to ...

Splenomegaly is a hallmark of myelofibrosis, a debilitating haematological malignancy for which the only curative option is allogeneic haematopoietic cell transplantation (HCT). Considerable splenic ...